CygnusMed

CygnusMed is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

CygnusMed develops an endovascular monitoring device called the EndoSphinx, which enables continuous arterial blood pressure measurement during endovascular procedures without requiring a second arterial line, reducing blood loss and procedural complications.